Mammography screening overdiagnoses women who may never have had clinical symptoms, finds a study the ACR said is incorrect and misleading.
Routine mammography screening results in overdiagnosis of breast cancer, diagnosing women who may never have had clinical symptoms, according to a study published in the most recent issue of the New England Journal of Medicine. However, the American College of Radiology argued the thesis of the article was incorrect and misleading.
The study authors searched through Surveillance, Epidemiology, and End Results data to examine trends from 1976 through 2008 for incidence of early-stage breast cancer (ductal carcinoma in situ and localized disease) and late-stage breast cancer (regional and distant disease) among women 40 years of age or older. Their findings revealed detection of early-stage breast cancer doubled from 112 to 234 cases per 100,000 women, an absolute increase of 122 cases per 100,000 women. Late-stage diagnosis decreased by 8 percent though, from 102 per 100,000 women to 94 cases per 100,000, an absolute decrease of 8 cases per 100,000 women.
The authors determined that only eight of the additional 122 additional early-stage cancers that were diagnosed were expected to advance to advanced disease. After adjusting for excess incidence associated with hormone-replacement therapy and trends of incidence in breast cancer in women under 40 years old, the authors determined that over the past 30 years, breast cancer was overdiagnosed in 1.3 million women. In 2008 alone, they estimated that 70,000 women (31 percent) were overdiagnosed with breast cancer.
The ACR claimed that the article was “deeply flawed and misleading” and based on false assumptions. According to the numbers provided by the ACR, the incidence was incorrectly determined:
“The authors suggest that the baseline incidence of breast cancer would have increased by 0.5 percent each year, when in fact, the data show that it would likely have increased by twice that amount,” the organization said in a statement. In 1980, before routine mammography screening, the incidence of breast cancer was 100 in 100,000 women, up from 60 in 100,000 in 1940. “If there had been no screening, and the rate continued to increase as it had for 40 years, the incidence in 2008 would have been over 130/100,000,” according to the ACR.
The overdiagnosis claimed by the study authors is more realistically the treatment of ductal carcinoma in situ (DCIS) that has reduced the incidence of invasive breast cancer, the ACR noted. “This is in addition to the observed 30 percent reduction in deaths each year due largely to screening.” The ACR stated that the authors failed to recognize that a reduction in advanced stage disease is not required to have a reduction in deaths from screening.
The ACR concluded that the study’s thesis was wrong, stating: “Misleading articles, based on fault assumptions and methodology are counterproductive. If such misinformation is used to determine screening guidelines and recommendations, the cost may be lost lives.”
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.